- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT04209322
Trial of Pulsed Radiofrequency for Sciatica and Disc Herniation (PRATS)
Transforaminal epidural injection of treatments, commonly steroids (TFESI), is offered to people with sciatica and might improve symptoms, reduce disability and speed up return to normal activities (NICE guidelines) Imaging-guided TFESI has traditionally been performed in the sciatica context because injection is administered directly to the nerve root, which relieves the pain markedly; however, the maintenance time is usually short.
Treatment with radiofrequency for pain management is in clinical use since decades primarily with nerve lesioning (thermoablation) once the specific pain tributary nerve is identified.
Pulsed radiofrequency (PRF) with neuromodulation intention (not lesioning) has been shown to be effective in reducing some types of chronic pain, both degenerative and neuropathic.
Pulsed radiofrequency has been also extensively used in the context of acute and subacute sciatica due to disc herniation without sufficient level of evidence. In a prospective RCT, comparing prf directed to dorsal root ganglia and Tfesi in patients with sciatica did not allow conclusions on efficacy because of limitations of the trial. In that trial, only few participants completed the study due to violation of trial protocol translating the results as not consistent.
One retrospective trial, in which the use of Prf in addition to tfesi was evaluated in patients with acute and subacute sciatica, demonstrated rapid pain relief onset and prolonged maintenance; the overall efficacy was superior to that of the single method treatment (either tfsei or prf).
The investigators conducted a randomized, double-blind, controlled trial (Pulsed Radiofrequency in Addition to Tfesi for Sciatica [PRATS]) to determine if PRF in addition to TFESI leads to better outcomes in the management of patients with acute and subacute sciatica due to disc herniation, compared to TFESI alone.
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
The investigators conducted a multicenter, prospective, randomized trial among patients with at least 6 weeks of sciatic pain to determine whether a strategy of PRF in addition to TFESI leads to better outcomes during the first year than does a strategy of TFESI only means for sciatica treatment.
Eligible patients were 18 to 75 years of age, had a radiologically confirmed disk herniation, and had received a diagnosis from an attending neurologist of an incapacitating lumbosacral radicular syndrome that had lasted for at least 12 weeks. Correlation of magnetic resonance imaging (MRI) findings with symptoms was registered. Patients presenting with cauda equina syndrome, muscle paralysis, or insufficient strength to move against gravity were excluded. Other exclusion criteria were cardiac pace-maker implant, pregnancy, or severe coexisting disease. The occurrence of another episode of symptoms similar to those of the current episode during the previous 12 months, previous spine surgery and spondylolisthesis were not considered contraindications but bony stenosis.
A computer-generated permuted-block scheme was used for randomization, with an unstratified variable-block size of 2 and 4. The order of blocks was also randomized with patients assigned (1:1) to PRF/TFESI (treatment) or TFESI (control). A few hours before randomization, the patients were evaluated again, and those who had recovered from their symptoms at that time were excluded from the trial.
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
-
Rome, Italy, 00100
- Alessandro Napoli
-
-
LT
-
Aprilia, LT, Italy, 04011
- Centro Sana
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- Eligible patients had radiologically confirmed disk herniation, and had received a diagnosis from an attending neurologist of an incapacitating lumbosacral radicular syndrome that had lasted for at least 12 weeks. Correlation of magnetic resonance imaging (MRI) findings with symptoms was required.
- The occurrence of another episode of symptoms similar to those of the current episode during the previous 12 months were not considered contraindications
Exclusion Criteria:
- Patients presenting with previous spine surgery, spondylolisthesis, cauda equina syndrome, muscle paralysis, or insufficient strength to move against gravity were excluded.
- Vertebral canal stenosis
- Other exclusion criteria were cardiac pace-maker implant, pregnancy, or severe coexisting disease.
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Double
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: Pulsed Radiofrequency
Aseptic technique was adopted.
Imaging guided (CT) catheter needle (active tip electrode) was inserted and a sensory stimulation test was carried out using an RF generator.
The catheter needle was then advanced toward the DRG until the patient reported a tingling sensation and/or dysesthesia at less than 0.3V.
PRF treatment was administered at 5 Hz and a 2 ms pulsed width for 10 minutes at 45V under the constraint that the electrode tip temperature not exceed 42°C.
Finally, patients received 1mL lidocaine 20mg/mL mixed with 2mL dexamethasone 10mg/mL.
|
Non-surgical treatment of lumbar disc herniation causing sciatica using pulsed radiofrequency (10 minutes) directed to the interested dorsal root ganglia (percutaneous technique); after radiofrequency application, using the same needle, steroid was administered (as per the control arm).
The procedure was guided by CT imaging
|
Active Comparator: Transforaminal Epidural Steroid Injection
Aseptic technique was adopted.
Imaging guided (CT) catheter needle (active tip electrode) was inserted and a sensory stimulation test was carried out using an RF generator.
The catheter needle was then advanced toward the DRG until the patient reported a tingling sensation and/or dysesthesia at less than 0.3V.
After 10 minutes await (as per pRF), patients received 1mL lidocaine 20mg/mL mixed with 2mL dexamethasone 10mg/mL.
|
Percutaneous injection of steroid in the nerve root foramen.
The procedure was guided by CT imaging
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Leg-Pain Intensity
Time Frame: 52 weeks
|
The primary outcome was the average leg-pain intensity score over the course of the previous 1 week (on a numerical pain-rating scale from 0 to 10, with 0 indicating no pain and 10 the worst possible pain; clinically important difference, 2 points), as assessed at 1 week and 52 weeks.
|
52 weeks
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Roland Morris disability questionnaire
Time Frame: 52 weeks
|
extent of disability as measured on the Roland Disability Questionnaire for Sciatica (scores range from 0 to 23, with higher scores indicating greater disability; clinically important difference, 8 points), as assessed at 4 weeks, 12 weeks and 52 weeks.
|
52 weeks
|
Oswestry Disability Index questionnaire
Time Frame: 52 weeks
|
extent of disability as measured on the Oswestry Disability Index (on a % scale from 0 to 100, version 2.0, MODEMS; clinically important difference, 10 points), as assessed at 4 weeks, 12 weeks and 52 weeks.
|
52 weeks
|
Pain change questionnaire
Time Frame: 52 weeks
|
global perceived effect (post-treatment symptoms as compared with baseline, on a scale from -5 [vastly worse] to 0 [unchanged], to +5 [completely recovered])
|
52 weeks
|
Other Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Adverse events
Time Frame: 52 weeks
|
Data regarding treatment-related side-effects will be registered.
|
52 weeks
|
workplace absenteeism questionnaire
Time Frame: 52 weeks
|
The cumulative number of days of workplace absenteeism due to sciatica
|
52 weeks
|
Satisfaction on current condition
Time Frame: 52 weeks
|
Subjective evaluation of current condition, expressed in terms of percentage, with 0% indicating completely disappointed and 100% indicating completely satisfied
|
52 weeks
|
Collaborators and Investigators
Sponsor
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- PRF003
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
IPD Sharing Time Frame
IPD Sharing Supporting Information Type
- Study Protocol
- Statistical Analysis Plan (SAP)
- Informed Consent Form (ICF)
- Clinical Study Report (CSR)
- Analytic Code
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Sciatica
-
Prince Sattam Bin Abdulaziz UniversityCompleted
-
University Hospital, MontpellierUnknown
-
Nantes University HospitalTerminatedDiscal SciaticaFrance
-
University of LahoreRecruitingPain | Acute SciaticaPakistan
-
Pakistan Institute of Medical SciencesRiphah International UniversityCompletedSciatica | Sciatica AcutePakistan
-
St George Hospital, AustraliaSt George & Sutherland Medical Research FoundationUnknown
-
Kyung Hee University Hospital at GangdongNational Research Foundation of KoreaUnknownChronic SciaticaKorea, Republic of
-
China Medical University HospitalCompletedBack Pain | Low Back Pain | Low Back Pain, Mechanical | Low Back Pain, Recurrent | Low Back Pain, Postural | Low Back Strain | Lumbago | Lumbago With Sciatica | Lumbago With Sciatica, Unspecified SideTaiwan
-
Assistance Publique - Hôpitaux de ParisCompletedPost Operative Sciatica by Lumbar Spinal FibrosisFrance
-
Centro Universitário Augusto MottaCompletedDisability Evaluation | Manual Therapies | Physical Therapy Modalities | Sciatica Pain
Clinical Trials on pulsed Radiofrequency
-
Hospital Son LlatzerRecruiting
-
Assiut UniversityNot yet recruiting
-
Basaksehir Cam & Sakura Şehir HospitalCompletedPain, Chronic | Facet Joint Pain | Pain SyndromeTurkey
-
Cukurova UniversityCompleted
-
Assiut UniversityUnknownTrigeminal Neuralgia | Pain, Neuropathic
-
Universitair Ziekenhuis BrusselUnknownChronic Disease | Lumbar RadiculopathyBelgium
-
Hospital Universitario La FeUnknown
-
University of Rome Tor VergataCompletedOsteoarthritis, Knee | Knee Arthritis | Knee Pain Chronic | Pulsed RadiofrequencyItaly
-
Allevio Pain Management ClinicRecruitingShoulder Pain Chronic | Faceto-genic Neck Pain | Faceto-genic HeadacheCanada